HAGLROS and gastric cancer: New evidence shows that lncRNA HAGLROS, an indicator of a poor prognosis in GC patients, strengthens GC cell proliferation and maintains the malignant phenotype by inhibiting autophagy through competitively interacting with miR-100-5p to further activate mTORC1 and alleviate the expression of ATG9 (57).